HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of International Conference on

Traditional Medicine, Ethnomedicine and Natural Therapies

June 20-22, 2024 | Paris, France

Traditional Medicine 2023

Krashenyuk Albert Ivanovich

Speaker at Traditional Medicine, Ethnomedicine and Natural Therapies 2023 - Krashenyuk Albert Ivanovich
Academy of Hirudotherapy, Russian Federation
Title : Pandemic “covid-19-postcovid syndrome”: This Name of the pandemic allows us to better understand the meaning of the use of hirudotherapy in treatment


The author of this message owns a series of publications in the period 2020-2022, highlighting the features of the pathogenesis of a new disease: "COVID-19-POST-COVID SYNDROME", as well as a method of treatment and prevention of this disease based on the scientifically proven medicinal properties of the medical leech Hirudo medicinalis. The editors of 4 scientific medical journals adopted the author's concept of the name of the disease - «COVID-19- POSTCOVID SYNDROME » (Open Access Journal of Biomedical Science,2022, May-June -4(3):1907-1909; J. of Medical & Clinical Nursing, 2022, Volume 3(4): 1- 9.; Journal of Clinical Epidemiology & Toxicology, 2022, Volume 3(4): 1-7.; PriMera Scientific Medicine and Public Health 1.4 (2022), 05-09). This suggests that there is an understanding of a single disease that has two phases: the first phase is an acute process, usually lasting 2-3 weeks ("COVID-19") and the second phase is the development of a chronic process s - "POSTCOVID SYNDROME", with duration of 18-24 months. This definition of a new pandemic is important not only from a taxonomic point of view, but above all from a mental point of view, since it gives the doctor an understanding of the complexity of the disease and requires monitoring patients throughout this period, for example, monitoring the dynamics of D-dimers, prothrombin time, platelet count and the level of fibrinogen in the blood of convalescents. Now, these are the most informative markers of the danger of thrombosis. The term "Long Covid" does not reflect the substance of the disease process. In addition, in this series of publications, we analyzed the most reasoned and proven various aspects of the pathogenesis of "COVID - 19 - POST-COVID SYNDROME".As a result of this campaign, our recommendations are as follows: in the acute period of the disease, we conduct leeching courses daily, and in the second phase of the disease - two sessions per week for 18-24 months. This technology is a serious alternative to oral anticoagulants and plasmapheresis. The use of direct anticoagulants has a number of significant contraindications and complications in the defeat of the central nervous system, can cause bleeding, nasal, throat and renal. Plasmapheresis is available only to well-equipped clinics. This alternative treatment is the use of the “System method of leeching” (SML). The proposed solution is based on almost 30- years of experience in the use of SML in elderly people with multi-organ pathology and children treated at the Academy of Hirudotherapy of St.- Petersburg. Our experience in the treatment of “Post-Covid syndrome 2020-2021. Shows, that it is possible, moreover, with high efficiency. Based on the analysis of the mechanisms of pathogenesis of the “COVID-19” virus, our article was published, in relation to the treatment of -«COVID-19- COVID-19-"POSTCOVID SYNDROME “ [1,2]. As the author of the mentioned publications, I want to note a whole series of works published in 2020-2022 in the different journals. In these works, a number of new fundamental data have been published that make it possible to evaluate hirudotherapy as a pathogenetic method of treating complications of “COVID-19- POSTCOVID SYNDROME", and vaccinations against coronavirus, regardless of its strain characteristics. These are the discoveries of new effects of hirudotherapy: energy, neuritstimulating, wave (acoustic), detoxification, negentropic, aquastructuring, antiviral, resonance-wave and others. In addition, the SML allows you to strengthen the therapeutic effect from synthetic drugs recommended by the national health centers of the world in the treatment of “COVID-19- POSTCOVID SYNDROME “. The proposed treatment technology has proven its effectiveness and the possibility of preventing complications from this disease in Russia, saved many lives.


Krashenyuk A.I.  graduated from the 1st Pavlov Medical Institute in 1971 in Leningrad, and postgraduate studies in biochemistry at the same institute in 1974 from Professor V.I. Rosengart.In 1974 he received the degree of Candidate of Medical Sciences. From 1974 to 1985 he worked as a senior researcher and head of the laboratory of biophysical methods  of  research at the Pasteur Institute in Leningrad. He was engaged in the development of vaccines against measles, mumps, influenza, tick-borne encephalitis. From 1985 to 1992 he headed the laboratory of live influenza vaccines and biophysical methods of  research . Created the world's first purified live influenza vaccine, which was vaccinated 4.5 million people without post-vaccination complications. In 1995 he received the degree of Doctor of Medical Sciences from the Institute of Influenza of the Russian Academy of Medical Sciences (RAS). One of the creators of space biotechnology for the production of highly purified viral proteins in microgravity. In 1996 and to the present time the creator of the world's first department and Academy of Hirudotherapy. Honorary Scientist of Europe, Academician of the European Academy of Natural Sciences (Germany), Grand Doctor in Biology and Medicine (Oxford), Full Professor of Oxford.